UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 448

Sortiert nach

CFOs and CEOs: Who have the most influence on earnings management?

Journal of financial economics, 2010-06, Vol.96 (3), p.513-526

2010

Volltextzugriff (PDF)

A web tool for designing and conducting phase I trials using the continual reassessment method

BMC cancer, 2018-02, Vol.18 (1), p.133-133, Article 133

2018

Volltextzugriff (PDF)

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Cancer, 2020-11, Vol.126 (22), p.4948-4956

2020

Volltextzugriff (PDF)

Earnings Management to Avoid Earnings Declines across Publicly and Privately Held Banks

The Accounting review, 2002-07, Vol.77 (3), p.547-570

2002

Volltextzugriff (PDF)

Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine

Journal of clinical oncology, 2011-07, Vol.29 (21), p.2924-2932

2011

Volltextzugriff (PDF)

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

Journal of clinical oncology, 2003-02, Vol.21 (4), p.607-614

2003

Volltextzugriff (PDF)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients

Journal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.163-13, Article 163

2019

Volltextzugriff (PDF)

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial

Clinical cancer research, 2009-11, Vol.15 (22), p.7036-7044

2009

Volltextzugriff (PDF)

Infrared thermography of cutaneous melanoma metastases

The Journal of surgical research, 2013-06, Vol.182 (1), p.e9-e14

2013

Volltextzugriff (PDF)

Comprehensive Income: Who's Afraid of Performance Reporting?

The Accounting review, 2010-01, Vol.85 (1), p.97-126

2010

Volltextzugriff (PDF)

Rainfall and topographic position determine tree embolism resistance in Amazônia and Cerrado sites

Environmental research letters, 2023-11, Vol.18 (11), p.114009

2023

Volltextzugriff (PDF)

The Impact of Early-Phase Trial Design in the Drug Development Process

Clinical cancer research, 2019-01, Vol.25 (2), p.819-827

2019

Volltextzugriff (PDF)

Activation of mitogen-activated protein kinase associated with prostate cancer progression

Cancer research (Chicago, Ill.), 1999-01, Vol.59 (2), p.279-284

1999

Volltextzugriff (PDF)

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e003220

2021

Volltextzugriff (PDF)

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Clinical cancer research, 2007-11, Vol.13 (21), p.6386-6395

2007

Volltextzugriff (PDF)

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Journal of clinical oncology, 2003-11, Vol.21 (21), p.4016-4026

2003

Volltextzugriff (PDF)

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

Journal for immunotherapy of cancer, 2017-11, Vol.5 (1), p.92-92, Article 92

2017

Volltextzugriff (PDF)

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

Clinical cancer research, 2012-01, Vol.18 (1), p.256-262

2012

Volltextzugriff (PDF)

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005424

2022

Volltextzugriff (PDF)

Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4973-4980

2008

Volltextzugriff (PDF)

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Journal for immunotherapy of cancer, 2023-12, Vol.11 (12), p.e007586

2023

Volltextzugriff (PDF)

Phase I Trial of Induction Histone Deacetylase and Proteasome Inhibition Followed by Surgery in Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2012-11, Vol.7 (11), p.1683-1690

2012

Volltextzugriff (PDF)

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine

Cancer Immunology, Immunotherapy, 2014-08, Vol.63 (8), p.779-786

2014

Volltextzugriff (PDF)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002214

2021

Volltextzugriff (PDF)

Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4474-4485

2004

Volltextzugriff (PDF)

1 – 25 von 448

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(394)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CFOs and CEOs: Who have the most influence on earnings management?

A web tool for designing and conducting phase I trials using the continual reassessment method

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Earnings Management to Avoid Earnings Declines across Publicly and Privately Held Banks

Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial

Infrared thermography of cutaneous melanoma metastases

Comprehensive Income: Who's Afraid of Performance Reporting?

Rainfall and topographic position determine tree embolism resistance in Amazônia and Cerrado sites

The Impact of Early-Phase Trial Design in the Drug Development Process

Activation of mitogen-activated protein kinase associated with prostate cancer progression

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups

Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Phase I Trial of Induction Histone Deacetylase and Proteasome Inhibition Followed by Surgery in Non–Small-Cell Lung Cancer

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist

Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule

Suchergebnisse filtern